Clinical Trial Update: Neuromodulation in Patients With Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial evaluating neuromodulation in pulmonary arterial hypertension; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Oklahoma | Conditions: Pulmonary Hypertension | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING